487 related articles for article (PubMed ID: 35235159)
21. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
22. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
23. mRNA Vaccines in the COVID-19 Pandemic and Beyond.
Hogan MJ; Pardi N
Annu Rev Med; 2022 Jan; 73():17-39. PubMed ID: 34669432
[TBL] [Abstract][Full Text] [Related]
24. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
Russell RL; Pelka P; Mark BL
Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic.
Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X
Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300
[TBL] [Abstract][Full Text] [Related]
26. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.
Noor R
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423150
[TBL] [Abstract][Full Text] [Related]
27. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
[TBL] [Abstract][Full Text] [Related]
28. [SARS-CoV-2 vaccines].
Benfield TL; Helweg-Larsen J
Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
[TBL] [Abstract][Full Text] [Related]
29. The find of COVID-19 vaccine: Challenges and opportunities.
ElBagoury M; Tolba MM; Nasser HA; Jabbar A; Elagouz AM; Aktham Y; Hutchinson A
J Infect Public Health; 2021 Mar; 14(3):389-416. PubMed ID: 33647555
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 vaccine: where are we now and where should we go?
Soleimanpour S; Yaghoubi A
Expert Rev Vaccines; 2021 Jan; 20(1):23-44. PubMed ID: 33435774
[TBL] [Abstract][Full Text] [Related]
31. The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses.
Muhar BK; Nehira J; Malhotra A; Kotchoni SO
J Pharm Pract; 2023 Aug; 36(4):953-966. PubMed ID: 35723017
[TBL] [Abstract][Full Text] [Related]
32. A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review.
Talukder A; Kalita C; Neog N; Goswami C; Sarma MK; Hazarika I
Z Naturforsch C J Biosci; 2022 Jul; 77(7-8):351-362. PubMed ID: 35245422
[TBL] [Abstract][Full Text] [Related]
33. Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review.
Chauhan N; Soni S; Gupta A; Aslam M; Jain U
J Med Virol; 2021 Apr; 93(4):1967-1982. PubMed ID: 33270225
[TBL] [Abstract][Full Text] [Related]
34. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.
Abdullahi IN; Emeribe AU; Adekola HA; Abubakar SD; Dangana A; Shuwa HA; Nwoba ST; Mustapha JO; Haruna MT; Olowookere KA; Animasaun OS; Ugwu CE; Onoja SO; Gadama AS; Mohammed M; Daneji IM; Amadu DO; Ghamba PE; Onukegbe NB; Shehu MS; Isomah C; Babayo A; Ahmad AE
Hum Vaccin Immunother; 2021 Mar; 17(3):620-637. PubMed ID: 32936732
[TBL] [Abstract][Full Text] [Related]
35. The COVID-19 vaccine development: A pandemic paradigm.
Carneiro DC; Sousa JD; Monteiro-Cunha JP
Virus Res; 2021 Aug; 301():198454. PubMed ID: 34015363
[TBL] [Abstract][Full Text] [Related]
36. Latest in COVID-19 Vaccine 'Candidates' Race.
Atoum MF; Zreig DA; Abu Zreig LM
Infect Disord Drug Targets; 2023; 23(1):e180822207640. PubMed ID: 35984031
[TBL] [Abstract][Full Text] [Related]
37. Deciphering Vaccines for COVID-19: where do we stand today?
Baviskar T; Raut D; Bhatt LK
Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):8-21. PubMed ID: 33054486
[TBL] [Abstract][Full Text] [Related]
38. A COVID-19 vaccine-dare to dream.
Phillis A
Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
[TBL] [Abstract][Full Text] [Related]
39. Coronavirus Vaccine: Light at the End of the Tunnel.
Ella KM; Mohan VK
Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
[TBL] [Abstract][Full Text] [Related]
40. A review of approved COVID-19 vaccines.
Jamkhande A; Khairnar MR; Gavali N; Patil Y; Kapare SS; Bhosale KP
Rocz Panstw Zakl Hig; 2021; 72(3):245-252. PubMed ID: 34553878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
